In Brief: Genzyme correction
This article was originally published in The Gray Sheet
Executive Summary
Genzyme correction: Genzyme Corp. has withdrawn its premarket approval application for its Sepracoat anti-adhesion product following a negative panel recommendation in May. "The Gray Sheet" incorrectly reported Sept. 1 (p. 3) that the PMA was sponsored by Genzyme Tissue Repair and was still pending at the agency...